- Home
- CRMD vs PHK Comparison
CRMD vs PHK Comparison
Compare CRMD & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- PHK
- Stock Information
- Founded
- CRMD 2006
- PHK 2003
- Country
- CRMD United States
- PHK United States
- Employees
- CRMD N/A
- PHK N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- PHK Finance/Investors Services
- Sector
- CRMD Health Care
- PHK Finance
- Exchange
- CRMD Nasdaq
- PHK Nasdaq
- Market Cap
- CRMD 464.7M
- PHK 769.6M
- IPO Year
- CRMD 2010
- PHK N/A
- Fundamental
- Price
- CRMD $9.10
- PHK $4.72
- Analyst Decision
- CRMD Strong Buy
- PHK
- Analyst Count
- CRMD 6
- PHK 0
- Target Price
- CRMD $14.50
- PHK N/A
- AVG Volume (30 Days)
- CRMD 1.6M
- PHK 491.5K
- Earning Date
- CRMD 05-08-2025
- PHK 01-01-0001
- Dividend Yield
- CRMD N/A
- PHK 12.61%
- EPS Growth
- CRMD N/A
- PHK N/A
- EPS
- CRMD N/A
- PHK N/A
- Revenue
- CRMD $43,472,170.00
- PHK N/A
- Revenue This Year
- CRMD $207.65
- PHK N/A
- Revenue Next Year
- CRMD $50.13
- PHK N/A
- P/E Ratio
- CRMD N/A
- PHK N/A
- Revenue Growth
- CRMD N/A
- PHK N/A
- 52 Week Low
- CRMD $3.61
- PHK $4.13
- 52 Week High
- CRMD $13.85
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- CRMD 62.22
- PHK 51.77
- Support Level
- CRMD $6.32
- PHK $4.53
- Resistance Level
- CRMD $7.71
- PHK $4.61
- Average True Range (ATR)
- CRMD 0.52
- PHK 0.13
- MACD
- CRMD 0.38
- PHK 0.02
- Stochastic Oscillator
- CRMD 97.22
- PHK 98.18
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.